tiprankstipranks
Perrigo Company (PRGO)
NYSE:PRGO
Want to see PRGO full AI Analyst Report?

Perrigo Company (PRGO) Price & Analysis

720 Followers

PRGO Stock Chart & Stats

$11.80
-$0.12(-0.48%)
At close: 4:00 PM EST
$11.80
-$0.12(-0.48%)

Bulls Say, Bears Say

Bulls Say
Market Share GainsSustained share gains in U.S. store-brand OTC and discrete branded wins in Europe reflect durable commercial strength and retailer trust. Private-label scale and category breadth create a structural advantage: each incremental household penetration point equates to meaningful, repeatable retail sales.
Positive Cash GenerationOperating and free cash flow remaining positive despite accounting losses shows resilient cash conversion and working-capital management. This provides funding for capex, dividends and deleveraging, giving the company a multi-month liquidity cushion while it executes cost and commercial recovery plans.
Balance Sheet & Capital ActionsProceeds from the Dermacosmetics sale plus an extended $1B revolver materially improve near-term liquidity and refinancing flexibility. These structural actions reduce immediate maturity pressure, allow targeted debt paydown, and strengthen the company's ability to execute its operational enhancement program.
Bears Say
Profitability DeteriorationA sustained swing to large TTM losses and multi-period revenue declines signal deeper demand, pricing or mix issues. Even with stable gross margins, below-the-line charges and impairments have eroded earnings power, reducing retained capital and limiting the firm's ability to reinvest for durable growth.
Elevated LeverageHigh absolute debt against a shrinking equity base constrains strategic flexibility and increases refinancing and covenant risk. Even with divestiture proceeds, leverage limits headroom for M&A or investment, and scheduled maturities (term loans and notes) may force refinancing or further asset sales if recovery stalls.
Leadership Transition RiskAn abrupt CEO resignation and interim leadership create execution risk at a critical turnaround stage. With results back‑half weighted and operational programs underway, management discontinuity could delay strategic initiatives, slow decision-making, and amplify execution risk during the recovery period.

Perrigo Company News

PRGO FAQ

What was Perrigo Company’s price range in the past 12 months?
Perrigo Company lowest stock price was $9.22 and its highest was $28.43 in the past 12 months.
    What is Perrigo Company’s market cap?
    Perrigo Company’s market cap is $1.42B.
      When is Perrigo Company’s upcoming earnings report date?
      Perrigo Company’s upcoming earnings report date is Aug 12, 2026 which is in 53 days.
        How were Perrigo Company’s earnings last quarter?
        Perrigo Company released its earnings results on May 06, 2026. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.307 by $0.123.
          Is Perrigo Company overvalued?
          According to Wall Street analysts Perrigo Company’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Perrigo Company pay dividends?
            Perrigo Company pays a Quarterly dividend of $0.29 which represents an annual dividend yield of 8.48%. See more information on Perrigo Company dividends here
              What is Perrigo Company’s EPS estimate?
              Perrigo Company’s EPS estimate is 0.34.
                How many shares outstanding does Perrigo Company have?
                Perrigo Company has 138,367,770 shares outstanding.
                  What happened to Perrigo Company’s price movement after its last earnings report?
                  Perrigo Company reported an EPS of $0.43 in its last earnings report, beating expectations of $0.307. Following the earnings report the stock price went up 5.333%.
                    Which hedge fund is a major shareholder of Perrigo Company?
                    Currently, no hedge funds are holding shares in PRGO
                    What is the TipRanks Smart Score and how is it calculated?
                    Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                      Company Description

                      Perrigo Company

                      Perrigo Company plc specializes in delivering readily available, non-prescription health and well-being products. Its core mission is to elevate personal health by empowering individuals to proactively manage or address common conditions without professional intervention. The company's operations are strategically divided into two main segments: Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas division is primarily focused on the creation, production, promotion, and sale of private label self-care products. These offerings span a diverse range of categories, including remedies for upper respiratory issues, pain relief and sleep aids, digestive health, nutritional items (such as vitamins, minerals, and supplements), healthy lifestyle products, skincare, personal hygiene, and oral self-care. This segment serves markets across the United States, Mexico, Canada, and South America. Its product portfolio includes well-known brands like Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. Conversely, the Consumer Self-Care International segment is dedicated to developing, manufacturing, marketing, and distributing consumer health brands. These products reach consumers through a comprehensive distribution network that includes pharmacies, wholesalers, drugstores, grocery retailers, and para-pharmacies. This segment operates in approximately 23 countries, with a primary focus on the European market. Beyond its own product lines, Perrigo also offers specialized contract manufacturing services. Established in 1887, Perrigo Company plc maintains its corporate headquarters in Dublin, Ireland.

                      Perrigo Company (PRGO) Earnings & Revenues

                      PRGO Company Deck

                      PRGO Earnings Call

                      Q1 2026
                      0:00 / 0:00
                      Earnings Call Sentiment|Neutral
                      The call presented a mixed picture: clear operational and commercial progress (market share gains, meaningful cost-savings program, completion of a divestiture and reaffirmed guidance) contrasted with material near-term revenue and margin headwinds (notably CORE net sales down ~8.3% YoY, gross/operating margin compression, a $331M goodwill impairment and cash flow pressure). Management emphasized these headwinds are largely transitory and the majority of growth and margin recovery is expected in the second half of 2026, supported by innovation, demand generation and operational improvements.View all PRGO earnings summaries

                      PRGO Stock 12 Month Forecast

                      Average Price Target

                      $17.00
                      ▲(44.07% Upside)
                      {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","26":"$26","13.25":"$13.25","17.5":"$17.5","21.75":"$21.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$17.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$17.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$17.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,13.25,17.5,21.75,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.76,11.24,11.72,12.2,12.68,13.16,13.64,14.120000000000001,14.6,15.08,15.56,16.04,16.52,{"y":17,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.76,11.24,11.72,12.2,12.68,13.16,13.64,14.120000000000001,14.6,15.08,15.56,16.04,16.52,{"y":17,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.76,11.24,11.72,12.2,12.68,13.16,13.64,14.120000000000001,14.6,15.08,15.56,16.04,16.52,{"y":17,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":24.607,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.27,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.543,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.141,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.994,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.343,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.202,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.269,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.65,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.027,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.721,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.617,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.76,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Viatris
                      Supernus Pharmaceuticals
                      Teva Pharmaceutical
                      Indivior
                      Amneal Pharmaceuticals

                      Ownership Overview

                      0.37%31.03%26.80%6.44%
                      26.80% Other Institutional Investors
                      6.44% Public Companies and
                      Individual Investors
                      Popular Stocks